Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGS19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CACTIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COPRS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KAAG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
COL15A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARIH2OS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM216B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF688 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC157 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF126P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP3D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH2D3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on